Ironshore
Pharmaceutical ManufacturingUnited States51-200 Employees
Ironshore is now part of Collegium Pharmaceutical, Inc. For the latest news and updates, please follow www.linkedin.com/company/collegium-pharmaceutical
Strategic Acquisition Ironshore's recent acquisition by Collegium Pharmaceutical for $525 million indicates a strong growth trajectory and increased product portfolio, presenting opportunities for cross-selling and expanded market reach within the pharmaceutical sector.
Product Launch Success The launch of JORNAY PM in 2019 for ADHD treatment positions Ironshore as a innovator in CNS disorders, opening avenues to market additional ADHD or similar therapeutic solutions to healthcare providers and clinics.
Regional Expansion Partnerships with Knight Therapeutics for exclusive distribution in Canada and Latin America suggest potential for additional licensing or distribution deals in emerging markets with a focus on CNS or specialty pharmaceuticals.
Financial Growth Potential With annual revenues between $25 million and $50 million and active product lines, Ironshore presents opportunities for sales growth through strategic partnerships, especially by leveraging its innovative product portfolio and recent corporate backing.
Technology & Engagement Ironshore’s use of modern web technologies and analytics indicates an emphasis on digital engagement and data-driven marketing, which can be harnessed for targeted outreach and personalized sales strategies within specialized pharmaceutical markets.
Ironshore uses 8 technology products and services including Bunny Fonts, Vue.js, jQuery Migrate, and more. Explore Ironshore's tech stack below.
| Ironshore Email Formats | Percentage |
| First.Last@ironshorepharma.com | 72% |
| First@ironshorepharma.com | 24% |
| Last.First@ironshorepharma.com | 2% |
| FirstL@ironshorepharma.com | 2% |
Pharmaceutical ManufacturingUnited States51-200 Employees
Ironshore is now part of Collegium Pharmaceutical, Inc. For the latest news and updates, please follow www.linkedin.com/company/collegium-pharmaceutical
Ironshore's revenue is estimated to be in the range of $25M$50M
Ironshore's revenue is estimated to be in the range of $25M$50M